HCA
LLY icon

Harbour Capital Advisors’s Eli Lilly LLY Stock Holding History

Harbour Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1M Sell
15,228
-82
-0.5% -$83.8K 3.3% 3
2026
Q1 		$14.1M Sell
15,310
-489
-3% -$496K 2.69% 5
2025
Q4 		$17.1M Sell
15,799
-224
-1% -$214K 3.47% 2
2025
Q3 		$13.5M Sell
16,023
-269
-2% -$200K 2.77% 4
2025
Q2 		$12.7M Sell
16,292
-7
-0% -$5.44K 2.68% 6
2025
Q1 		$12.9M Sell
16,299
-2,248
-12% -$1.87M 3.18% 1
2024
Q4 		$14.5M Sell
18,547
-9
-0% -$7.45K 3.23% 3
2024
Q3 		$17.1M Sell
18,556
-186
-1% -$167K 3.94% 1
2024
Q2 		$17.1M Sell
18,742
-75
-0.4% -$60K 4.07% 1
2024
Q1 		$14.4M Sell
18,817
-69
-0.4% -$49.1K 3.56% 1
2023
Q4 		$11.7M Buy
18,886
+29
+0.2% +$16.9K 3.2% 3
2023
Q3 		$10.1M Buy
18,857
+191
+1% +$98.4K 3.04% 4
2023
Q2 		$8.61M Sell
18,666
-288
-2% -$121K 2.54% 4
2023
Q1 		$6.51M Sell
18,954
-2,341
-11% -$790K 1.97% 7
2022
Q4 		$7.77M Sell
21,295
-665
-3% -$236K 2.61% 5
2022
Q3 		$7.11M Sell
21,960
-30
-0.1% -$9.51K 2.47% 5
2022
Q2 		$7.13M Sell
21,990
-153
-0.7% -$45.9K 2.32% 5
2022
Q1 		$6.34M Sell
22,143
-1,502
-6% -$387K 1.73% 10
2021
Q4 		$6.53M Buy
23,645
+206
+0.9% +$52.2K 1.61% 10
2021
Q3 		$5.42M Buy
23,439
+252
+1% +$62.2K 1.43% 15
2021
Q2 		$5.32M Buy
23,187
+29
+0.1% +$5.83K 1.43% 17
2021
Q1 		$4.33M Buy
23,158
+115
+0.5% +$22.5K 1.27% 20
2020
Q4 		$4K Buy
23,043
+121
+0.5% +$18.1K 1.99% 19
2020
Q3 		$3.39M Buy
22,922
+519
+2% +$80.3K 1.24% 24
2020
Q2 		$3.68M Sell
22,403
-165
-0.7% -$25.3K 1.49% 14
2020
Q1 		$3.13M Sell
22,568
-6
-0% -$824 1.59% 13
2019
Q4 		$2.97M Sell
22,574
-343
-1% -$39.8K 1.14% 22
2019
Q3 		$2.56M Buy
22,917
+1,146
+5% +$128K 1.08% 22
2019
Q2 		$2.41M Buy
21,771
+210
+1% +$24.7K 1.03% 21
2019
Q1 		$2.8M Sell
21,561
-4,099
-16% -$498K 1.24% 20
2018
Q4 		$2.97M Sell
25,660
-955
-4% -$107K 1.47% 12
2018
Q3 		$2.86M Sell
26,615
-490
-2% -$49K 1.15% 18
2018
Q2 		$2.33M Buy
27,105
+1,295
+5% +$106K 1% 23
2018
Q1 		$2M Buy
25,810
+3,137
+14% +$253K 0.85% 27
2017
Q4 		$1.92M Buy
22,673
+622
+3% +$52.9K 0.8% 26
2017
Q3 		$1.89M Buy
22,051
+1,330
+6% +$109K 0.82% 28
2017
Q2 		$1.71M Sell
20,721
-545
-3% -$44.5K 0.85% 26
2017
Q1 		$1.79M Buy
21,266
+1,720
+9% +$138K 0.82% 25
2016
Q4 		$1.44M Buy
19,546
+4,775
+32% +$356K 1.03% 21
2016
Q3 		$1.19M Buy
14,771
+4,825
+49% +$386K 0.74% 30
2016
Q2 		$783K Sell
9,946
-1,408
-12% -$106K 0.44% 80
2016
Q1 		$818K Buy
11,354
+4,740
+72% +$359K 0.47% 73
2015
Q4 		$557K Buy
6,614
+1,935
+41% +$161K 0.3% 113
2015
Q3 		$392K Buy
+4,679
New +$395K 0.28% 125

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

Harbour Capital Advisors's LLY Position: Q2 2026 in Review

Harbour Capital Advisors reduced its Eli Lilly (LLY) stake by 0.54% in Q2 2026, selling an estimated $83.8K and leaving 15,228 shares worth $18.1M. The position accounts for 3.3% of the portfolio, ranked #3.

Harbour Capital Advisors first reported a position in LLY in Q3 2015 and has held it in 44 quarters since. 1,171 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Harbour Capital Advisors held 15,228 shares of Eli Lilly worth $18.1M as of Q2 2026.
  • Harbour Capital Advisors sold 82 Eli Lilly shares in Q2 2026, an estimated $83.8K.
  • Eli Lilly made up 3.3% of Harbour Capital Advisors's portfolio in Q2 2026, its #3 holding.
  • Harbour Capital Advisors first reported a position in Eli Lilly in Q3 2015 and has held it in 44 quarters since.
  • 1,171 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.